Buckingham Palace: King Charles Under Observation After Treatment Side Effects

London: Britain’s King Charles underwent a brief period of medical observation in hospital on Thursday after experiencing temporary side effects from his ongoing cancer treatment, Buckingham Palace announced. Royal sources described the issue as minor and not a cause for major concern.

Below is the full statement from Buckingham Palace:

“Following scheduled and ongoing medical treatment for cancer this morning, The King experienced temporary side effects that required a short period of observation in hospital. His Majesty’s afternoon engagements were therefore postponed.

His Majesty has now returned to Clarence House and as a precautionary measure, acting on medical advice, tomorrow’s diary programme will also be rescheduled.

His Majesty would like to send his apologies to all those who may be inconvenienced or disappointed as a result.”

Also Read | Washington Restores Short-Term Funding for Ukraine Child Abduction Tracker

King Charles, who was diagnosed with cancer earlier this year, has continued to fulfill his royal duties while undergoing treatment. Despite occasional adjustments to his schedule, Buckingham Palace has consistently emphasized his commitment to public service.

Also Read | Bolsonaro Escapes Charges in Vaccine Fraud Case Due to Lack of Evidence

Recent News

US Prosecutors to Seek Death Penalty for Luigi Mangione, Bondi Confirms

New York: U.S. Attorney General Pamela Bondi has directed federal prosecutors to pursue the death penalty against Luigi Mangione, who stands accused of fatally...

Xi Urges Stronger China-India Ties in ‘Dragon-Elephant Tango’

Beijing: Chinese President Xi Jinping has urged closer cooperation between China and India, describing their relationship as a "Dragon-Elephant tango". In a message to...

Alembic Pharmaceuticals Limited Announces USFDA Final Approval for Pantoprazole Sodium for Injection, 40 mg/vial (Single-Dose Vial)

Mumbai: Alembic Pharmaceuticals Limited (Alembic) announced that it has received Final Approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug...

Bharti AXA Life Insurance appoints Prerak Parmar as Chief Growth Officer

Kolkata: Bharti AXA Life continues to strengthen its leadership team by hiring seasoned professionals with deep domain expertise and a strong track record in driving...